Novartis Says To Probe Charge By Ex-Sales Rep On Bribes To Doctors
This article was originally published in PharmAsia News
Executive Summary
A former Novartis International AG’s drug sales representative has claimed the Swiss firm asked her to bribe doctors under cover of product education to sell Sandostatin LAR Depot (octreotide Acetate Microspheres for Injection), with the company saying it will probe the charges.